Searched for
ACTAVIS PHARMA MANUFACTURING LTD
Intas & Dr Reddy's in race with PEs to buy US' AthenexAthenex, which is into the development of cell therapies to treat cancers, had hired investment advisory firm Cowen Inc to run a formal pro...- Top domestic pharma companies in US probe for price-fixingDomestic majors — including Sun Pharma, Lupin and Aurobindo Pharma — along with US biggies Sandoz, Pfizer and Mylan have been charged with ...
- Aurobindo buys US units of Sandoz for $900 millionThe acquired business has been carved out by the management of Sandoz for divestment.
- Aurobindo Pharma to buy Portugal's Generis for 135 mn euroAurobindo Pharma has inked an agreement through its subsidiary Agile Pharma BV Netherlands to acquire Generis Farmaceutica.
- Intas buys Teva's UK & Ireland assets for $764 million to break into global top 20 generic players clubWith the acquisition of Teva’s products, sold through erstwhile Actavis’ operations, Intas is set to emerge as a top player in the UK gener...
- Glenmark Pharma gets USFDA nod for two generic drugsQuoting IMS data, Glenmark Pharma said the approved product has an estimated market size of $74.1 million for the 12 months ended November ...
- Aurobindo, Actavis recall Gabapentin capsulesThe drug is manufactured by Aurobindo Pharma at its Mahabub Nagar facility in Andhra Pradesh.
- Aurobindo Pharma eyes $2 billion revenues in FY15The consolidated revenue (net) from operations was higher over the previous year by 38.3 per cent at nearly Rs 8,100 crore during 2013-14.
- Sun Pharma to buy Ranbaxy in $3.2 bn deal“This is the biggest deal we have done, but not the most difficult one,” said Sun Pharma chairman Dilip Shanghvi.
- Glenmark in talks to sell oral contraceptive unitThe company promoted by Glenn Saldanha has begun talks with some of the leading local and global drugmakers.
- Vivimed acquires Actavis Pharma's facility for Rs 122 croreVivimed Labs today said it has acquired a manufacturing facility of Actavis Pharma Manufacturing Ltd for a total consideration of Rs 122 cr.
- US court bans Sun from selling Eloxatin: Sanofi AventisFrench drug maker Sanofi Aventis SA on Friday said a New Jersey US district court ordered Sun Pharma to stop selling its generic version of...
- Regenix beefs Board, goes for out-of-court settlement with StridesRegenix promoter Dr A Ramamurthy made waves in the pharma circuit in 2007. That was when the physician-entrepreneur sold the marketing righ...
- Pfizer charges Sun with another patent violationA legal battle between Pfizer and Sun Pharmaceutical has escalated.
- Small firms all set to pep up pharma retailOrganised pharma retail, dominated by the likes of Apollo and Subiksha, is set for more action at the regional level.
- TEVA TO buy local unit for Rs 400 crThe world’s largest generic drug manufacturer Teva may be close to acquiring domestic company Saraca Labs’ manufacturing plant in Hyderabad...
- Cipla, PEs team up for Merck's bizRanbaxy Lab, Teva Corp, Actavis and Mylan are among the cos short listed in the first round.
- Actavis acquires Sanmar subsidiaryActavis Group, the global generic pharma company, has announced the acquisition of the Active Pharmaceutical Ingredient (API).
- Cos exit generics for core focusAs international generics drug markets reel under increasing pricing pressure and ever-rising competition, big pharma companies are selling...
- Actavis acquires Grandix manufacturing plantActavis Group, an international generic pharmaceuticals company has acquired the three-year-old manufacturing factory of Chennai-based Gran...
Load More
